# HARMONi-A (NCT05184712)

> Phase 3 Clinical Study of AK112 for NSCLC Patients

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05184712
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Akeso
- Conditions: Non-Squamous Non-small Cell Lung Cancer
- Interventions: Ivonescimab (SMT112 or AK112) Injection; Placebo Injection
- Enrollment: 322
- Primary outcome: Progression-free survival (PFS)

## Indexed commentary on HARMONi-A so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 48
- Podcasts: 25
- YouTube: 20

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=harmoni-a-nct05184712

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05184712", "email": "<work email>"}; the inbox owner confirms by the emailed link.